Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06987370) titled 'SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue' on May 16.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Shandong Cancer Hospital and Institute
Condition:
Bone Metastases in Subjects With Advanced Cancer
Intervention:
Radiation: Conventional Radiotherapy (CRT)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 30, 2025
Target Sample Size: 90
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/sho...